Perrigo Company plc Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
Perrigo Company plc (PRGO) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of $29.20 million as of 2015-12-31, per its 10-Q filed 2016-11-10.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2016-11-10
- 2015-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $29.20M.
- 2015-03-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $2.98B.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net |
|---|---|
| 2015-12-31 | $29.20M 10-Q · filed 2016-11-10 |
| 2015-03-30 | $2.98B 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |